Latest Legal News | Orlando Legal Examiner

Bausch & Lomb Lawsuit Filing Today

This afternoon I’ll be filing a civil lawsuit against Bausch & Lomb, the manufacturer of ReNu contact lens solution. I’ll be filing in US District Court for the Middle District of Florida on behalf of a woman who has lost nearly 80% of her vision in her left eye. Unfortunately, she is not a surgical

By The Legal Examiner

/ 27 Apr 2006

FDA Experts' Conflicts of Interest

As a governmental oversight agency, it should be appalling that the FDA uses experts who have financial interests in the drugs and products about which they provide expert testimony. Yet, in a study conducted by the consumer group Public Citizen, that is exactly what is happening. How can any expert

By The Legal Examiner

/ 26 Apr 2006

ReNu with MoistureLoc Victims Growing

The Centers for Disease Control and Prevention have confirmed that there are 24 new cases of fusarium keratitis. This brings the total to 54, up from 30 just two weeks ago. In the midst of new cases, Bausch & Lomb, the manufacturer of ReNu remains slow to react to the mounting crisis.

By The Legal Examiner

/ 24 Apr 2006

Vioxx According to Jurors

There’s an insightful article in the online version of the Wall St. Journalregarding what jurors think when it comes to the pharmaceutical giant Merck and their drug Vioxx. The article states that three things are important when it comes to prevailing in a lawsuit against the maker of Vioxx: 1)show

By The Legal Examiner

/ 24 Apr 2006

Court Documents Show Ortho McNeil Knew Ortho Evra Was Lethal

Documents have surfaced in litigation that show Ortho-McNeil has been analyzing the FDA’s death and injury reports on women using the Ortho Evra birth-control patch, and has charts that show a higher rate of blood clots and deaths in women on the patch when compared to women who take birth-control p

By The Legal Examiner

/ 24 Apr 2006

GAO Criticizes FDA on How it Handles Drugs

The Government Accountability Office has published a report sharply critical of the Food and Drug Administration. The report states that the organization is sometimes too slow in recognizing safety problems once drugs have gone to market. The GAO report also says the FDA does not have clear policies

By The Legal Examiner

/ 24 Apr 2006

FDA Says Throw Out ReNu with MoistureLoc

Bausch & Lomb, the maker of contact lens solution ReNu with MoistureLoc may have acted hesitantly when it failed to voluntarily pull its product off store shelves but not so for the FDA. Yesterday, the FDA issued a statement that consumers should immediately stop using the product and discard any re

By The Legal Examiner

/ 22 Apr 2006

FDA & CDC Still Looking for Source of ReNu Fungus

The US FDA and the Centers for Disease Control are still looking for the source and cause of the fusarium keratitis fungus that forced Bausch & Lomb to halt shipments of its once popular contact lens solution ReNu with MoistureLoc. Bausch & Lomb’s chief medical officer, Brian Levy, stated that “I th

By The Legal Examiner

/ 21 Apr 2006

InfecciÃ³n Ocular y la SoluciÃ³n ReNu con MoistureLoc hecho por la compania Bausch & Lomb

InfecciÃ³n ocular por hongos puede causar vision borrosa, dolor en los ojos, e irritaciÃ³n. El hongo fusarium se encuentra comÃºnamente en las plantas y la tierra de regiones tropicales (como Florida). Sin el tratatamiento de gotas oftÃ¡lmicas que puede durar de dos a tres meses la infecciÃ³n puede

By The Legal Examiner

/ 20 Apr 2006

ReNu: Florida's Dubious Distinction

Fellow InjuryBoard blogger attorney Bob Carroll has an excellent post on the latest news on the Bausch & Lomb ReNu contact lens solution problem.

By The Legal Examiner

/ 20 Apr 2006

ReNu Contact Lens Solution Update

While the investigation is ongoing, we know thus far that of 30 cases in the US studied by the Centres for Disease Control and Prevention, 28 patients wore soft contact lenses and 26 had used the Bausch & Lomb ReNu brand contact lens solution in the month before the onset of the infection. Eight pat

By The Legal Examiner

/ 18 Apr 2006

FDA Continues its Bausch & Lomb Investigation

In an effort to locate the source of the fungal infection in suspected cases of Fusarium keratitis, the FDA is continuing its investigation of Bausch & Lomb plants. Of the 30 cases that have been reviewed by the Centers for Disease Control and Prevention, 26 people reported using a Bausch & Lomb ReN

By The Legal Examiner

/ 17 Apr 2006